Surface Oncology, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2018 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Surface Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2018 to Q2 2023.
  • Surface Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $1.19M, a 42.8% decline year-over-year.
  • Surface Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $6.12M, a 21.8% decline year-over-year.
  • Surface Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.22M, a 15.5% decline from 2021.
  • Surface Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.55M, a 10.1% increase from 2020.
  • Surface Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $7.77M, a 29.6% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $6.12M $1.19M -$887K -42.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $7M $1.65M -$219K -11.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $7.22M $1.52M -$324K -17.6% Oct 1, 2022 Dec 31, 2022 8-K 2023-07-03
Q3 2022 $7.55M $1.77M -$278K -13.6% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $7.83M $2.07M -$206K -9.04% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $8.03M $1.87M -$515K -21.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $8.55M $1.84M -$109K -5.58% Oct 1, 2021 Dec 31, 2021 8-K 2023-07-03
Q3 2021 $8.66M $2.04M +$81K +4.13% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $8.57M $2.28M +$279K +14% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $8.3M $2.38M +$530K +28.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $7.77M $1.95M +$407K +26.3% Oct 1, 2020 Dec 31, 2020 8-K 2023-07-03
Q3 2020 $7.36M $1.96M +$397K +25.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $6.96M $2M +$515K +34.7% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $6.45M $1.85M +$455K +32.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $5.99M $1.55M +$323K +26.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-02
Q3 2019 $5.67M $1.57M +$352K +29% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $5.32M $1.49M -$5K -0.34% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $5.32M $1.4M +$104K +8.06% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $5.22M $1.22M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-09
Q3 2018 $1.21M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.49M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $1.29M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.